O'Shaughnessy Asset Management, LLC Precigen, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$1.27 - $2.26 $22,503 - $40,044	17,719 New	17,719 $26,000
Q4 2021 Feb 11, 2022	SELL	$3.53 - $5.5 $12,831 - $19,992	-3,635 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$4.99 - $6.55 $5,698 - $7,480	-1,142 Reduced 23.91%	3,635 $18,000
Q2 2021 Aug 09, 2021	SELL	$6.24 - $8.22 $68,877 - $90,732	-11,038 Reduced 69.79%	4,777 $31,000
Q4 2020 Feb 11, 2021	BUY	$3.75 - $10.56 $59,306 - $167,006	15,815 New	15,815 $161,000

142

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $235M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.